All software under review was downloaded from the manufacturers' Web sites from December 2002 to July 2003. The following software was evaluated: ePocrates Rx (v. 6.0), Tarascon PharmacopoeiaDeluxe ...
NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, announced the launch of Software-Enhanced Drug™ therapies, part of ...
The US Food and Drug Administration (FDA) has released draft guidance with considerations on how to include software outputs of drug use-related software in prescription labeling. In the draft ...
New technologies continue to emerge that improve care for patients taking prescription medications. On September 18, 2023, five years after the Food and Drug Administration sought initial public ...
On September 19, 2023, the U.S. Food and Drug Administration (“FDA” or “the Agency”) published a draft guidance, Regulatory Considerations for Prescription Drug Use-Related Software (the “Guidance”) ...
Stakeholders want the US Food and Drug Administration (FDA) to narrow its scope of what it considers labeling in a draft guidance for prescription drug-use-related software (PDURS) frameworks, with ...
Merck KGaA has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and app-based approaches in rare oncology – marking the first big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results